Sam Martin

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Sam Martin

Earlier roles on record: CFO at Celldex Therapeutics, Inc. (CLDX) until March 31, 2027. Sam Martin has spoken on 1 earnings call across 1 company, most recently for Celldex Therapeutics, Inc. on August 6, 2020.

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Sam Martin's recent earnings-call comments and cite the source calls.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Celldex Therapeutics, Inc. (CLDX)
CFO

Proxy statement

Start not stated–2027-03-31

Company network

Recorded roles and call appearances connecting this person to public companies.

Celldex Therapeutics, Inc.

CLDX

CFO

1 appearance Latest appearance 2020-08-06

View calls and events

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Earnings call Celldex Therapeutics, Inc. Q2 FY2020 Earnings Call Celldex Therapeutics, Inc. (CLDX)
2020-08-06